This agreement is DePuy Synthes Spine’s first move into cellular allografts for spinal fusion.
LifeNet Health is a developer of allograft bioimplants and cellular therapies.
More Articles on Devices:
Texas Hospital Purchases Second Renaissance Spine System From Mazor Robotics
Smith & Nephew to Purchase ArthroCare for $1.7B
Global Medical Device Market to Reach $434.4B by 2017
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
